employer cover photo
employer logo
employer logo

Covidien

Acquired by Medtronic

Is this your company?

Covidien reviews

3.3

57% would recommend to a friend

(813 total reviews)

Omar Ishrak

78% approve of CEO

38% positive business outlook

Covidien has an employee rating of 3.3 out of 5 stars, based on 813 company reviews on Glassdoor which indicates that most employees have a good working experience there. The Covidien employee rating is in line with the average (within 1 standard deviation) for employers within the Manufactura industry (3.5 stars).

Reviews by job title

813 reviews
3.0
Oct 25, 2011

A learning experience

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Good benefits, and good co-workers

Cons

Information is limited, opportunities are not advertised.

5.0
Oct 6, 2011
Recommend
CEO approval
Business Outlook

Pros

Covidien is increasing its footprint in India in a great way. The top management from corporate has great committment to put covidien on the map of India. The R&D centre is a very enriching place to work, for all R&D engineers who aspire to make a difference in medical device domain would find wrking at covidien R&D a great experience. It give excellent global exposure to its employees and opportunities to grow and prove oneself are immense.

Cons

the brand needs to establish itself in India as its not well known yet

2.0
Sep 29, 2011
Recommend
CEO approval
Business Outlook

Pros

Low overhead in MO together with reasonable wages promotes ability to save $$$ for retirement, college, etc. Management opportunities for experienced newcomers are very good in drug development due to expansion of branded pharmaceuticals pipeline. Some colleagues are capable, bright, and friendly. Nice campus. Most people leave by 5:00-5:30 PM.

Cons

Public announcements of intentions to sell off Pharmaceuticals, Generics, and API businesses (i.e. the Missouri site) since April of 2011 cause great uncertainty. Senior management's vision to expand branded pharmaceuticals is poorly executed- aversion to risk, short-sightedness in developing a deep pipeline, and lack of innovation in the approach leads to small, incremental improvements to existing generics. These products must then compete in mature marketplaces as branded drugs at a high cost.

Viewing 223 - 225 of 813 Reviews

Glassdoor has 921 Covidien reviews submitted anonymously by Covidien employees. Read employee reviews and ratings on Glassdoor to decide if Covidien is right for you.